Marine n-3 Polyunsaturated Fatty Acids in Patients With End-stage Renal Failure and in Subjects Without Kidney Disease: A Comparative Study

Journal of Renal Nutrition

Volumn 21, Issue 2, 2011, Pages 169-175

  Madsen, Trine ^a   Christensen, Jeppe H ^a   Svensson, My ^a   Witt, Petra M ^a   Toft, Egon ^b   Schmidt, Erik B ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PHOSPHOLIPID;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; DENMARK; DIET SUPPLEMENTATION; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ARACHIDONIC ACID; CARDIOVASCULAR DISEASES; DENMARK; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHOSPHOLIPIDS; RENAL DIALYSIS;

EID: 79951575833     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2010.06.020     Document Type: Article

References (40)

1. Lavie C.J., Milani R.V., Mehra M.R., et al. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol 2009, 54:585-594.
2. Sarnak M.J., Levey A.S., Schoolwerth A.C., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003, 108:2154-2169.
3. Atlas of End Stage Renal disease in the United States: Morbidity and mortality. Am J Kidney Dis 2009, 53:S211-S226.
4. Friedman A., Moe S. Review of the effects of omega-3 supplementation in dialysis patients. Clin J Am Soc Nephrol 2006, 1:182-192.
5. Kutner N.G., Clow P.W., Zhang R., et al. Association of fish intake and survival in a cohort of incident dialysis patients. Am J Kidney Dis 2002, 39:1018-1024.
6. Friedman A.N., Saha C., Watkins B.A. Feasibility study of erythrocyte long-chain omega-3 polyunsaturated fatty acid content and mortality risk in hemodialysis patients. J Ren Nutr 2008, 18:509-512.
7. Friedman A.N., Moe S.M., Perkins S.M., et al. Fish consumption and omega-3 fatty acid status and determinants in long-term hemodialysis. Am J Kidney Dis 2006, 47:1064-1071.
8. Saifullah A., Watkins B.A., Saha C., et al. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients-a pilot study. Nephrol Dial Transplant 2007, 22:3561-3567.
9. Svensson M., Schmidt E.B., Jorgensen K.A., et al. N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial. Clin J Am Soc Nephrol 2006, 1:780-786.
10. Witt P.M., Christensen J.H., Ewertz M., et al. The incorporation of marine n-3 PUFA into platelets and adipose tissue in pre- and postmenopausal women: a randomised, double-blind, placebo-controlled trial. Br J Nutr 2010, 104:318-325.
11. Christensen J.H., Skou H.A., Fog L., et al. Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography. Circulation 2001, 103:651-657.
12. Folch J., Lees M., Sloane-Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
13. Burdge G.C., Wright P., Jones A.E., et al. A method for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid-phase extraction. Br J Nutr 2000, 84:781-787.
14. van Kuijk F.J., Thomas D.W., Stephens R.J., et al. Gas chromatography-mass spectrometry method for determination of phospholipid peroxides: I. transesterification to form methyl esters. J Free Radic Biol Med 1985, 1:215-225.
15. Kris-Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757.
16. Fouque D., Vennegoor M., ter W.P., et al. EBPG guideline on nutrition. Nephrol Dial Transplant 22:ii45-ii87 2007, (suppl 2).
17. K/DOQI Workgroup: K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005, 45:S1-S153.
18. Koorts A.M., Viljoen M., Kruger M.C. Red blood cell fatty acid profile of chronic renal failure patients receiving maintenance haemodialysis treatment. Prostaglandins Leukot Essent Fatty Acids 2002, 67:13-18.
19. Peck L.W., Monsen E.R., Ahmad S. Effect of three sources of long-chain fatty acids on the plasma fatty acid profile, plasma prostaglandin E2 concentrations, and pruritus symptoms in hemodialysis patients. Am J Clin Nutr 1996, 64:210-214.
20. Ristic V., Tepsic V., Ristic-Medie D., et al. Plasma and erythrocyte phospholipid fatty acids composition in Serbian hemodialyzed patients. Ren Fail 2006, 28:211-216.
21. Dasgupta A., Kenny M.A., Ahmad S. Abnormal fatty acid profile in chronic hemodialysis patients: possible deficiency of essential fatty acids. Clin Physiol Biochem 1990, 8:238-243.
22. An W.S., Kim S.E., Kim K.H., et al. Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients. J Ren Nutr 2009, 19:267-274.
23. Cao J., Schwichtenberg K.A., Hanson N.Q., et al. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem 2006, 52:2265-2272.
24. Herzog C.A., Mangrum J.M., Passman R. Sudden cardiac death and dialysis patients. Semin Dial 2008, 21:300-307.
25. Siscovick D.S., Raghunathan T.E., King I., et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995, 274:1363-1367.
26. Albert C.M., Campos H., Stampfer M.J., et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002, 346:1113-1118.
27. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999, 354:447-455.
28. Calder P.C. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006, 83:1505S-1519S.
29. Pecoits-Filho R., Lindholm B., Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome-the heart of the matter. Nephrol Dial Transplant 2002, 17(suppl 11):28-31.
30. Schmidt E.B. Marine n-3 fatty acids and thrombosis. Thromb Res 2003, 111:9-10.
31. Schmitz P.G., McCloud L.K., Reikes S.T., et al. Prophylaxis of hemodialysis graft thrombosis with fish oil: double-blind, randomized, prospective trial. J Am Soc Nephrol 2002, 13:184-190.
32. Bowden R.G., Wilson R.L., Gentile M., et al. Effects of omega-3 fatty acid supplementation on vascular access thrombosis in polytetrafluorethylene grafts. J Ren Nutr 2007, 17:126-131.
33. Lok C.E., Allon M., Donnelly S., et al. Design of the fish oil inhibition of stenosis in hemodialysis grafts (FISH) study. Clin Trials 2007, 4:357-367.
34. Irish A., Dogra G., Mori T., et al. Preventing AVF thrombosis: the rationale and design of the omega-3 fatty acids (fish oils) and aspirin in vascular access outcomes in renal disease (FAVOURED) study. BMC Nephrol 2009, 10:1.
35. Svensson M., Schmidt E.B., Jorgensen K.A., et al. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study. Nephrol Dial Transplant 2008, 23:2918-2924.
36. Sarnak M.J., Coronado B.E., Greene T., et al. Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol 2002, 57:327-335.
37. Harris W.S., von Schacky C. The omega-3 index: a new risk factor for death from coronary heart disease?. Prev Med 2004, 39:212-220.
38. Harris W.S., Sands S.A., Windsor S.L., et al. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 2004, 110:1645-1649.
39. Nakao T., Matsumoto H., Okada T., et al. Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis. Intern Med 1998, 37:826-830.
40. Joy M.S., Cefalu W.T., Hogan S.L., et al. Long-term glycemic control measurements in diabetic patients receiving hemodialysis. Am J Kidney Dis 2002, 39:297-307.